Northern Trust Corp Logic Bio Therapeutics, Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.03 - $7.57 $593,993 - $1.12 Million	-147,393 Reduced 83.26%	29,636 $131,000
Q1 2021 May 12, 2021	SELL	$6.8 - $9.16 $34,727 - $46,780	-5,107 Reduced 2.8%	177,029 $1.29 Million
Q4 2020 Feb 11, 2021	BUY	$5.29 - $9.1 $248,936 - $428,227	47,058 Added 34.84%	182,136 $1.39 Million
Q3 2020 Nov 16, 2020	SELL	$5.41 - $9.45 $31,210 - $54,517	-5,769 Reduced 4.1%	135,078 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$4.25 - $8.46 $169,447 - $337,300	39,870 Added 39.48%	140,847 $1.19 Million
Q1 2020 May 14, 2020	BUY	$4.06 - $11.0 $62,422 - $169,125	15,375 Added 17.96%	100,977 $499,000
Q4 2019 Feb 14, 2020	SELL	$7.01 - $11.01 $2,264 - $3,556	-323 Reduced 0.38%	85,602 $616,000
Q3 2019 Nov 13, 2019	SELL	$6.97 - $13.46 $20,659 - $39,895	-2,964 Reduced 3.33%	85,925 $929,000
Q2 2019 Aug 13, 2019	BUY	$9.77 - $17.08 $9,164 - $16,021	938 Added 1.07%	88,889 $1.16 Million
Q1 2019 May 13, 2019	BUY	$7.93 - $10.41 $31,577 - $41,452	3,982 Added 4.74%	87,951 $869,000
Q4 2018 Feb 12, 2019	BUY	$7.88 - $17.98 $661,675 - $1.51 Million	83,969 New	83,969 $873,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.